Political cycles and transitional justice: Evidence from Uruguay and Chile
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
This study concentrates on how countries deal with the mass human rights violations, large-scale massacres, and social abuses experienced during authoritarian rule. A comparative research is conducted, focusing on the differences and similarities between societies governed by bureaucratic authoritarian systems. Uruguay and Chile are studied as similar cases that have ended up with different outcomes in transitional justice processes. The main question of the study is whether and how political cycles affect transitional justice policies. It is assumed that successive leftist governments in power can better serve transitional justice. However, despite the successive electoral victories of the left in Uruguay and its relatively longer control over the executive, it is concluded that the country could not perform better than Chile, where left and right-wing actors alternated in the executive.
Author
Tuçe Genç
Institution
How to Cite
Tuçe Genç (Master Thesis). Political cycles and transitional justice: Evidence from Uruguay and Chile, 2023, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)